Meloxicam, Rizatriptan
SYMBRAVO
Nonsteroidal Anti-inflammatory Drug
NADAC/unit
$122.7633
No Shortage
Meloxicam, Rizatriptan reduces pain, inflammation, and fever by inhibiting prostaglandin synthesis.
vs. brand SYMBRAVO: Generic saves up to -1128% per unit
Generic Manufacturers
AXSOME THERAPEUTICS INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
